Loading organizations...
§ Private Profile · Cambridge, MA, USA
Developing small molecule therapeutics for protein homeostasis disorders.
Proteostasis Therapeutics has raised $37.0M across 1 funding round.
Proteostasis Therapeutics has raised $37.0M in total across 1 funding round.
Proteostasis Therapeutics has raised $37.0M in total across 1 funding round.
Proteostasis Therapeutics's investors include Bihua Chen, dRx Capital, Elan Science One, F-Prime Capital, HealthCare Ventures, New Enterprise Associates, Rock Springs Capital, Sanofi Ventures.
Proteostasis Therapeutics has raised $37.0M across 1 funding round. Most recently, it raised $37.0M Series B in September 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 8, 2015 | $37M Series B | Bihua Chen | DRX Capital, Elan Science ONE, F Prime Capital, HealthCare Ventures, NEW Enterprise Associates, Rock Springs Capital, Sanofi Ventures | Announced |